MedPath

Pantoprazole Sodium

These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM FOR INJECTION safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM FOR INJECTION. PANTOPRAZOLE SODIUM for injection, for intravenous useInitial U.S. approval: 2000

Approved
Approval ID

b90163d1-3425-42d6-adf3-b9da0e70389a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 5, 2024

Manufacturers
FDA

Methapharm, Inc.

DUNS: 066672887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pantoprazole Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67850-150
Application NumberANDA209524
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pantoprazole Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2023
FDA Product Classification

INGREDIENTS (3)

PANTOPRAZOLE SODIUMActive
Quantity: 40 mg in 10 mL
Code: 6871619Q5X
Classification: ACTIM
EDETATE DISODIUMInactive
Quantity: 1 mg in 10 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pantoprazole Sodium - FDA Drug Approval Details